TRANSACTION CO.,Ltd. (7818.T)
JPY 2143.0
(-2.86%)
JPY 2143.0
(-2.86%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 4.17 Billion JPY | -4.37% |
| 2023 | 4.36 Billion JPY | 32.37% |
| 2022 | 3.29 Billion JPY | 6.39% |
| 2021 | 3.09 Billion JPY | -10.53% |
| 2020 | 3.46 Billion JPY | 16.86% |
| 2019 | 2.96 Billion JPY | 8.71% |
| 2018 | 2.72 Billion JPY | 6.08% |
| 2017 | 2.56 Billion JPY | 3.74% |
| 2016 | 2.47 Billion JPY | 7.27% |
| 2015 | 2.3 Billion JPY | -4.03% |
| 2014 | 2.4 Billion JPY | 3.5% |
| 2013 | 2.32 Billion JPY | 9.32% |
| 2012 | 2.12 Billion JPY | 10.89% |
| 2011 | 1.91 Billion JPY | 1.57% |
| 2010 | 1.88 Billion JPY | -23.07% |
| 2009 | 2.45 Billion JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 3.52 Billion JPY | -19.3% |
| 2024 Q4 | 4.17 Billion JPY | 19.28% |
| 2024 Q3 | 3.49 Billion JPY | -12.55% |
| 2024 Q2 | 3.99 Billion JPY | 13.6% |
| 2023 Q4 | 4.36 Billion JPY | 12.61% |
| 2023 FY | 4.36 Billion JPY | 32.37% |
| 2023 Q1 | 3.29 Billion JPY | -0.11% |
| 2023 Q2 | 3.8 Billion JPY | 15.7% |
| 2023 Q3 | 3.87 Billion JPY | 1.7% |
| 2022 Q3 | 2.52 Billion JPY | -14.15% |
| 2022 Q1 | 2.93 Billion JPY | -5.15% |
| 2022 FY | 3.29 Billion JPY | 6.39% |
| 2022 Q4 | 3.29 Billion JPY | 30.78% |
| 2022 Q2 | 2.93 Billion JPY | -0.09% |
| 2021 Q3 | 2.65 Billion JPY | -14.5% |
| 2021 Q2 | 3.1 Billion JPY | -3.68% |
| 2021 FY | 3.09 Billion JPY | -10.53% |
| 2021 Q4 | 3.09 Billion JPY | 16.62% |
| 2021 Q1 | 3.22 Billion JPY | -6.85% |
| 2020 Q3 | 3.06 Billion JPY | 6.83% |
| 2020 FY | 3.46 Billion JPY | 16.86% |
| 2020 Q1 | 2.78 Billion JPY | -6.01% |
| 2020 Q2 | 2.86 Billion JPY | 2.98% |
| 2020 Q4 | 3.46 Billion JPY | 13.01% |
| 2019 FY | 2.96 Billion JPY | 8.71% |
| 2019 Q4 | 2.96 Billion JPY | 14.76% |
| 2019 Q3 | 2.58 Billion JPY | 3.47% |
| 2019 Q2 | 2.49 Billion JPY | -2.08% |
| 2019 Q1 | 2.54 Billion JPY | -6.51% |
| 2018 Q4 | 2.72 Billion JPY | 11.81% |
| 2018 FY | 2.72 Billion JPY | 6.08% |
| 2018 Q3 | 2.43 Billion JPY | -3.58% |
| 2018 Q2 | 2.52 Billion JPY | 3.01% |
| 2018 Q1 | 2.45 Billion JPY | -4.47% |
| 2017 Q2 | 2.15 Billion JPY | -13.75% |
| 2017 FY | 2.56 Billion JPY | 3.74% |
| 2017 Q1 | 2.49 Billion JPY | 0.78% |
| 2017 Q4 | 2.56 Billion JPY | 12.16% |
| 2017 Q3 | 2.29 Billion JPY | 6.41% |
| 2016 Q4 | 2.47 Billion JPY | 2.24% |
| 2016 FY | 2.47 Billion JPY | 7.27% |
| 2016 Q3 | 2.42 Billion JPY | 6.36% |
| 2016 Q1 | 2.62 Billion JPY | 13.62% |
| 2016 Q2 | 2.27 Billion JPY | -13.18% |
| 2015 Q2 | 2.33 Billion JPY | -11.8% |
| 2015 Q1 | 2.64 Billion JPY | 9.88% |
| 2015 Q3 | 2.38 Billion JPY | 2.08% |
| 2015 FY | 2.3 Billion JPY | -4.03% |
| 2015 Q4 | 2.3 Billion JPY | -3.0% |
| 2014 Q3 | 2.36 Billion JPY | 19.72% |
| 2014 Q2 | 1.97 Billion JPY | -21.34% |
| 2014 Q1 | 2.5 Billion JPY | 7.96% |
| 2014 Q4 | 2.4 Billion JPY | 1.8% |
| 2014 FY | 2.4 Billion JPY | 3.5% |
| 2013 Q1 | 2.05 Billion JPY | -3.14% |
| 2013 Q4 | 2.32 Billion JPY | 9.1% |
| 2013 FY | 2.32 Billion JPY | 9.32% |
| 2013 Q3 | 2.13 Billion JPY | 7.21% |
| 2013 Q2 | 1.98 Billion JPY | -3.51% |
| 2012 Q4 | 2.12 Billion JPY | -5.76% |
| 2012 Q1 | 1.99 Billion JPY | 3.86% |
| 2012 Q2 | 2.07 Billion JPY | 4.02% |
| 2012 FY | 2.12 Billion JPY | 10.89% |
| 2012 Q3 | 2.25 Billion JPY | 8.92% |
| 2011 Q1 | 1.93 Billion JPY | 2.65% |
| 2011 Q3 | 2.1 Billion JPY | 17.43% |
| 2011 FY | 1.91 Billion JPY | 1.57% |
| 2011 Q4 | 1.91 Billion JPY | -8.76% |
| 2011 Q2 | 1.78 Billion JPY | -7.65% |
| 2010 FY | 1.88 Billion JPY | -23.07% |
| 2010 Q4 | 1.88 Billion JPY | 0.0% |
| 2009 FY | 2.45 Billion JPY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Kitanotatsujin Corporation | 1.65 Billion JPY | -152.438% |
| Euglena Co., Ltd. | 37.92 Billion JPY | 88.998% |
| BEAUTY GARAGE Inc. | 6.49 Billion JPY | 35.74% |
| Axas Holdings Co.,Ltd. | 14.58 Billion JPY | 71.386% |
| C.I. Medical Co.,Ltd. | 21.36 Billion JPY | 80.474% |
| Kao Corporation | 757.7 Billion JPY | 99.449% |
| Niitaka Co., Ltd. | 9.35 Billion JPY | 55.409% |
| Rohto Pharmaceutical Co.,Ltd. | 99.13 Billion JPY | 95.792% |
| Shiseido Company, Limited | 615.1 Billion JPY | 99.322% |
| Lion Corporation | 188.22 Billion JPY | 97.783% |
| Mandom Corporation | 20.05 Billion JPY | 79.198% |
| Ivy Cosmetics Corporation | 1.32 Billion JPY | -214.447% |
| Milbon Co., Ltd. | 7.45 Billion JPY | 44.071% |
| Nippon Shikizai, Inc. | 13.56 Billion JPY | 69.233% |
| Fancl Corporation | 30.56 Billion JPY | 86.351% |
| KOSÉ Corporation | 88.61 Billion JPY | 95.292% |
| Cota Co., Ltd. | 3.85 Billion JPY | -8.291% |
| HABA Laboratories,Inc. | 3.92 Billion JPY | -6.319% |
| C'bon Cosmetics Co.,Ltd. | 3.14 Billion JPY | -32.495% |
| Pola Orbis Holdings Inc. | 33.26 Billion JPY | 87.457% |
| Noevir Holdings Co., Ltd. | 24.04 Billion JPY | 82.646% |
| Adjuvant Holdings Co.,Ltd. | 1.06 Billion JPY | -292.079% |
| Almado, Inc. | 1.94 Billion JPY | -114.351% |
| I-ne CO., LTD. | 8.57 Billion JPY | 51.363% |
| Premier Anti-Aging Co., Ltd. | 4.88 Billion JPY | 14.507% |
| Liberta Co.,Ltd. | 3.88 Billion JPY | -7.429% |
| AXXZIA Inc. | 2 Billion JPY | -107.933% |
| S.T. Corporation | 12.01 Billion JPY | 65.265% |
| Kobayashi Pharmaceutical Co., Ltd. | 62.65 Billion JPY | 93.341% |
| Earth Corporation | 60.4 Billion JPY | 93.093% |
| Sagami Rubber Industries Co., Ltd. | 7.79 Billion JPY | 46.5% |
| Asahi Eito Holdings Co.,Ltd. | 1.61 Billion JPY | -158.646% |
| Ya-Man Ltd. | 3.97 Billion JPY | -4.92% |
| MTG Co., Ltd. | 11.73 Billion JPY | 64.46% |
| SHOBIDO Corporation | 8.89 Billion JPY | 53.108% |
| Artnature Inc. | 23.42 Billion JPY | 82.191% |
| Pigeon Corporation | 19.34 Billion JPY | 78.438% |
| Unicharm Corporation | 345.37 Billion JPY | 98.792% |
| Paltac Corporation | 222.34 Billion JPY | 98.124% |
| CB GROUP MANAGEMENT Co., Ltd. | 28.51 Billion JPY | 85.368% |